AstraZeneca\'s Imfinzi meets endpoint at Phase 3 interim analysis in extensivestage small cell lung cancer httpbit.ly2X9iLrf pharma LungCancerpic.twitter.comZq6GeIZQE8

AstraZeneca's Imfinzi meets endpoint at Phase 3 interim analysis in extensive-stage small cell lung #cancer http://bit.ly/2X9iLrf  #pharma #LungCancerpic.twitter.com/Zq6GeIZQE8

07:01 EDT 27 Jun 2019 | Pharmafile

AstraZeneca's Imfinzi meets endpoint at Phase 3 interim analysis in extensive-stage small cell lung #cancer http://bit.ly/2X9iLrf  #pharma #LungCancer pic.twitter.com/Zq6GeIZQE8

More From BioPortfolio on "AstraZeneca's Imfinzi meets endpoint at Phase 3 interim analysis in extensive-stage small cell lung #cancer http://bit.ly/2X9iLrf  #pharma #LungCancerpic.twitter.com/Zq6GeIZQE8"